SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 23.82 |
| Enterprise Value ($M) | 14.45 |
| Book Value ($M) | 72.03 |
| Book Value / Share | 1.88 |
| Price / Book | 0.33 |
| NCAV ($M) | 19.84 |
| NCAV / Share | 0.52 |
| Price / NCAV | 1.20 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.72 |
| Return on Assets (ROA) | -0.37 |
| Return on Equity (ROE) | -0.51 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.16 |
| Current Ratio | 3.16 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 57.15 |
| Assets | 109.33 |
| Liabilities | 37.30 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Citadel Advisors Llc | 0.00 | ||
| 13G/A | Tang Capital Partners Lp | 9.60 | 33.67 | |
| 13G/A | Vivo Capital VIII, LLC | 5.50 | ||
| 13D/A | Pivotal bioVenture Partners Fund I, L.P. | 8.10 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 131,282 | 376,617 | 34.86 | |
| 8,212 | 29,559 | 27.78 | |
| 35,024 | 100,160 | 34.97 | |
| 12,921 | 48,353 | 26.72 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BLUE – bluebird bio, Inc. | BMEA – Biomea Fusion, Inc. |
| BMRN – BioMarin Pharmaceutical Inc. | BPMC – Blueprint Medicines Corporation |
| CABA – Cabaletta Bio, Inc. |
Financial data and stock pages provided by
Fintel.io